In breast cancer, up-regulated snoRNAs can serve as fibrillarin binding oncogenes to block p53 activation, while SNORD50A and SNORD50B act as tumor suppressor genes, whose deletions lead to p53 degradation to promote tumor progression [24,25]. Here, TP53 is linked to breast cancer.